[Form 4] Kenvue Inc. Insider Trading Activity

Rhea-AI Filing Summary

NVIDIA Corp. (NVDA) – Form 144 filing discloses that President/CEO Jen-Hsun Huang intends to sell 75,000 common shares through Charles Schwab on 08 Aug 2025. At the filing’s reference price, the block is valued at $13.36 million, representing a small fraction of the company’s ~24.4 billion shares outstanding.

The notice also itemises 2,175,000 shares that Huang has already sold between 20 Jun 2025 and 01 Aug 2025. Gross proceeds from those 30 transactions total $358.9 million, with sale sizes of 50 k–75 k shares executed almost daily. The shares being registered for sale were acquired via an option exercise on 15 Sep 2023 and paid for in cash.

Form 144 is only a notification and does not guarantee the sale will occur, but the filing confirms the executive’s intent and highlights the continued disposal of sizeable positions by NVIDIA’s top insider within a short period.

Insights

Securities Analyst

TL;DR: CEO plans fresh 75 k-share sale after unloading 2.18 m shares (~$359 m) in six weeks – sentiment negative.

Frequent, large-scale insider sales by the CEO can weigh on investor sentiment, particularly given NVDA’s premium valuation. Though Form 144 does not mandate execution, Huang has consistently completed similar blocks almost daily, suggesting high likelihood of follow-through. Cumulatively, 2.25 m shares (including the proposed block) amount to ~$372 m in potential cash realised. The percentage of float is immaterial, but the optics of sustained selling amid elevated share price could spark concerns about near-term upside and prompt portfolio rebalancing. Market should monitor any 10b5-1 plan details, which are not specified in the filing.

Corporate Governance Expert

TL;DR: Repeated insider disposals raise governance & signaling questions despite compliance with Rule 144.

While Rule 144 filings are routine, magnitude and cadence matter: 30 prior sales plus a fresh notice within seven weeks may be interpreted as management de-risking. Absence of a disclosed 10b5-1 adoption date limits transparency, potentially inviting investor scrutiny over timing relative to earnings cycles. Nonetheless, the filing affirms the signer’s representation of no undisclosed adverse information. From a governance lens, boards often balance executive liquidity needs with market optics; greater disclosure around trading plans would help mitigate perception risk.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Perry Kirk

(Last) (First) (Middle)

1 KENVUE WAY

(Street)

SUMMIT NJ 07901

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Kenvue Inc. [ KVUE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
07/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	07/31/2025		A		117,150		(2)	(2)	Common Stock	117,150	$0	117,150	D
Stock Options	$21.44	07/31/2025		A		614,250		(2)	07/31/2025	Common Stock	614,250	$0	614,250	D

Explanation of Responses:

1. These units correspond 1 for 1 with the Company's common stock.

2. This award will vest in full on 7/14/2026, subject to the reporting person's continued service through such vesting date.

Remarks:

	/s/ Alla Berenshteyn, as attorney-in-fact	08/04/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.